Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Bridges

Showing results (101-110 of 110) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 110 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2002
Epithelial ovarian cancer metastasizing to the brain: a late manifestation of the disease with an increasing incidenceDesiree F Kolomainen, James M G Larkin, Mohammad Badran, et al.
Cancer Research|July 16, 2020
<i>RAD51AP1</i> Deficiency Reduces Tumor Growth by Targeting Stem Cell Self-RenewalAllison E Bridges, Sabarish Ramachandran, Rajneesh Pathania, et al.
Science (New York, N.Y.)|November 14, 2015
Torque-mixing magnetic resonance spectroscopyJ E Losby, F Fani Sani, D T Grandmont, et al.
Oncogene|June 14, 2016
The BET inhibitor JQ1 selectively impairs tumour response to hypoxia and downregulates CA9 and angiogenesis in triple negative breast cancerL L da Motta, I Ledaki, K Purshouse, et al.
Hereditary Cancer in Clinical Practice|November 25, 2011
Screening for ovarian cancer in women with varying levels of risk, using annual tests, results in high recall for repeat screening testsMarielle Ae Nobbenhuis, Elizabeth Bancroft, Eleanor Moskovic, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 6, 2023
Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancerE C de Heer, C E Zois, E Bridges, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 27, 2023
Correction: Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancerE C de Heer, C E Zois, E Bridges, et al.
Molecular Cancer Research : MCR|June 8, 2021
RAD51AP1 Loss Attenuates Colorectal Cancer Stem Cell Renewal and Sensitizes to ChemotherapyAllison E Bridges, Sabarish Ramachandran, Kavin Tamizhmani, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2024
Hippocampus Glutathione S Reductase Potentially Confers Genetic Resilience to Cognitive Decline in the AD-BXD Mouse PopulationMichael C Saul, Elizabeth M Litkowski, Niran Hadad, et al.
Gastroenterology|August 26, 2018
Evidence of Chronic Allograft Injury in Liver Biopsies From Long-term Pediatric Recipients of Liver TransplantsSandy Feng, John C Bucuvalas, Anthony J Demetris, et al.
Pageof 11

Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2002
Epithelial ovarian cancer metastasizing to the brain: a late manifestation of the disease with an increasing incidenceDesiree F Kolomainen, James M G Larkin, Mohammad Badran, et al.
Cancer Research|July 16, 2020
<i>RAD51AP1</i> Deficiency Reduces Tumor Growth by Targeting Stem Cell Self-RenewalAllison E Bridges, Sabarish Ramachandran, Rajneesh Pathania, et al.
Science (New York, N.Y.)|November 14, 2015
Torque-mixing magnetic resonance spectroscopyJ E Losby, F Fani Sani, D T Grandmont, et al.
Oncogene|June 14, 2016
The BET inhibitor JQ1 selectively impairs tumour response to hypoxia and downregulates CA9 and angiogenesis in triple negative breast cancerL L da Motta, I Ledaki, K Purshouse, et al.
Hereditary Cancer in Clinical Practice|November 25, 2011
Screening for ovarian cancer in women with varying levels of risk, using annual tests, results in high recall for repeat screening testsMarielle Ae Nobbenhuis, Elizabeth Bancroft, Eleanor Moskovic, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 6, 2023
Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancerE C de Heer, C E Zois, E Bridges, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 27, 2023
Correction: Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancerE C de Heer, C E Zois, E Bridges, et al.
Molecular Cancer Research : MCR|June 8, 2021
RAD51AP1 Loss Attenuates Colorectal Cancer Stem Cell Renewal and Sensitizes to ChemotherapyAllison E Bridges, Sabarish Ramachandran, Kavin Tamizhmani, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2024
Hippocampus Glutathione S Reductase Potentially Confers Genetic Resilience to Cognitive Decline in the AD-BXD Mouse PopulationMichael C Saul, Elizabeth M Litkowski, Niran Hadad, et al.
Gastroenterology|August 26, 2018
Evidence of Chronic Allograft Injury in Liver Biopsies From Long-term Pediatric Recipients of Liver TransplantsSandy Feng, John C Bucuvalas, Anthony J Demetris, et al.
Pageof 11